---
title: "Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291144397.md"
description: "In Boston on June 29, 2026, Elicio Therapeutics, Inc. (Nasdaq: ELTX) revealed that it has been included in the Russell 2000 ® and Russell 3000 ® Indexes. This change came into effect after the U.S. market closed on June 26, 2026, during the annual reconstitution of the 2026 Russell indexes. Elicio is a clinical-stage biotechnology company focused on developing advanced immunotherapies for cancers fueled by KRAS."
datetime: "2026-06-29T12:02:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291144397.md)
  - [en](https://longbridge.com/en/news/291144397.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291144397.md)
---

# Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes

In Boston on June 29, 2026, Elicio Therapeutics, Inc. (Nasdaq: ELTX) revealed that it has been included in the Russell 2000 ® and Russell 3000 ® Indexes. This change came into effect after the U.S. market closed on June 26, 2026, during the annual reconstitution of the 2026 Russell indexes. Elicio is a clinical-stage biotechnology company focused on developing advanced immunotherapies for cancers fueled by KRAS.

### Related Stocks

- [ELTX.US](https://longbridge.com/en/quote/ELTX.US.md)

## Related News & Research

- [Elicio opens Phase 1 neoadjuvant ELI-002 7P trial in resectable pancreatic cancer at MSK](https://longbridge.com/en/news/295403408.md)
- [Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering | ELTX Stock News](https://longbridge.com/en/news/291495074.md)
- [Erasca rilis presentasi korporat soal pengembangan terapi kanker berbasis jalur RAS/MAPK](https://longbridge.com/en/news/295578619.md)
- [Winklevoss-Backed Zcash faces Funding Crunch As $37.8M loss Puts Cancer Drug In The Spotlight](https://longbridge.com/en/news/295885103.md)
- [11:16 ETBIOSAPIEN - THE REVOLUTIONARY CANCER PLATFORM DEVELOPER - NOMINATED AS "BEST STARTUP" IN THE 2026 PRIX GALIEN USA AWARDS](https://longbridge.com/en/news/295952681.md)